Telemetry Investments, L.L.C. / REGN
Telemetry Investments, L.L.C.’s Regeneron Pharmaceuticals Position
Does Telemetry Investments, L.L.C. own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 2.5K shares worth $1M in Q3 2020; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$1M
Q3 2020
Shares
2.5K
% of Portfolio
+3.04%
Quarters Held
2
position exited
Position History REGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Telemetry Investments, L.L.C.’s full portfolio or all institutional holders of REGN.